摘要: Anti-CTLA-4 antibodies are disclosed. Also disclosed compositions comprising such antibodies, and uses methods using the same.
lens.org 参考文章(39)
Sanjeev Mariathasan, Heather Maecker, Bryan Irving, Henry Chiu, Jeanne Cheung, Yan Wu, Sophie M. Lehar, Anti-pd-l1 antibodies and their use to enhance t-cell function ,(2009)
Linda Liu, Michael Glen Overstreet, Solomon Langerman, Sheng Yao, B7-h4 specific antibodies, and compositions and methods of use thereof ,(2013)
Nathalie Scholler, Denarda Dangaj, Aizhi Zhao, Daniel J. Powell, Isolated B7-H4 specific compositions and methods of use thereof ,(2012)
D. M. Sansom, CD28, CTLA-4 and their ligands: who does what and to whom? Immunology. ,vol. 101, pp. 169- 177 ,(2000) , 10.1046/J.1365-2567.2000.00121.X
J. Yun Tso, Yong-Jun Liu, Laura Bover, Shankar Kumar, Naoya Tsurushita, Kui Shin Voo, Anti-ox40 antibodies and methods of using the same ,(2011)
Chetana Rao-Naik, Josephine M. Cardarelli, David J. King, Bingliang Chen, Jonathan A. Terrett, Anti-b7h4 monoclonal antibody-drug conjugate and methods of use ,(2008)
Michael Tesar, Ute Jaeger, Anti-CD38 human antibodies and uses thereof ,(2005)
Michel De Weers, Jan Van De Winkel, Yvo Graus, Martine Van Vugt, Judith Oprins, Paul Parren Parren, Antibodies against cd38 for treatment of multiple myeloma ,(2006)
Michel Sadelain, Renier Brentjens, Isabelle Rivière, The Basic Principles of Chimeric Antigen Receptor Design Cancer Discovery. ,vol. 3, pp. 388- 398 ,(2013) , 10.1158/2159-8290.CD-12-0548
Christopher Daly, Xunbao Duan, Douglas MacDonald, Anti-ErbB3 Antibodies and Uses Thereof ,(2012)